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Previewsmonomers and oligomers. The result of
their tour de force is that the peak-to-
peak distances in the force extension
curves from simulations are nearly iden-
tical to those observed in the experi-
ments, strongly supporting that the
simple coarse-grained model accurately
captures the mechanical unfolding mech-
anisms observed in experiments. The
simulations revealed that when force is
applied to fibrinogen, the g nodule
partially unfolds, and the coiled coils
reversibly convert from an a-helical
to an extended b strand structure. The
authors then suggest that these two
mechanisms may explain the extraordi-
nary elasticity and extensibility of fibrin
fibers. These mechanisms have been
proposed before, but a clear verification
was still missing, and the authors provide
convincing evidence that these mecha-
nisms are indeed feasible.
A limitation of the experimental and
simulation designs is that they could not
probe the role of the flexible, unstructured1538 Structure 19, November 9, 2011 ª2011a-C region. This is because single fibrin-
ogen molecules or short chains of abut-
ting monomers were tested, rather than
double-stranded, half-staggered protofi-
brils, or even complete fibers. There is
emerging evidence that the a-C region
plays a significant role in fibrin fiber forma-
tion, especially in protofibril assembly,
and it has been suggested that the
stretching and unfolding of the a-C region
may be the major molecular mechanism
that endows fibrin fibers with their large
extensibility (Houser et al., 2010).
It is also entirely possible that all
three mechanisms (Figure 2) could be
going on in parallel. Thus, in the future it
would be exciting to perform the forced
unfolding experiments and simulations
with protofibrils.REFERENCES
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The recognition of pathogen surfaces by mannan-binding lectin activates MASP proteases, leading to
complement activation. A crystal structure by Gingras et al. (2011) in this issue of Structure now shows
how the collagen-like stems of mannan-binding lectin bind MASP-1 through a minimalist set of interactions.Collagen is the most abundant protein
in vertebrates. Its basic structure was
workedout over 50 years agoandconsists
of three polypeptide chains with charac-
teristic Gly-X-Y repeats that are inter-
twined to form a left-handed triple helix
(Brodsky and Persikov, 2005). Gly-X-Y
repeats are not confined to collagens,
however, and short stretches of the motif
are also found in a number of proteins of
the immune system, such as the macro-
phage scavenger receptor A, the comple-
ment protein C1q, and mannan-binding
lectin (MBL). MBL and the closely-related
ficolins play an important role in innateimmunity; their binding to carbohydrate
arrayson thesurfaceofpathogens triggers
the activation of complement (Wallis et al.,
2010). This process critically involves
the MBL-associated serine proteases
(MASPs), which, upon binding to a path-
ogen surface, are converted from inactive
zymogens to active proteases. How this
happens is still unclear, but an important
piece of the puzzle is now provided by
Gingras et al. (2011) in this issue of Struc-
ture, who have determined a crystal struc-
ture of the MBL-MASP contact region.
The basic unit of MBL is a homotrimer
consisting of a collagen-like stem, ana-helical-coiled coil neck region, and
three globular carbohydrate recognition
domains. Circulating MBL contains two
or more of these homotrimers covalently
linked at their N-termini by a number of di-
sulphide bonds (Figure 1). This structure
is commonly likened to a bouquet of
flowers. MASPs are homodimers with
a modular architecture; their N-terminal
CUB-EGF-CUB regions mediate binding
to MBL, and their C-terminal regions
contain the serine proteases that auto-
activate upon pathogen recognition. A
previous elegant study by Wallis et al.
(2004) mapped the MASP binding site to
Figure 1. Schematic Drawing of the MBL-MASP
Complex Bound to a Pathogen Surface
An interruption to the Gly-X-Y repeats in the collagen-like
stems of MBL is shown as a kink. Calcium ions are shown as
magenta circles. MASP is shown in the activated state result-
ing from pathogen binding. CRD, carbohydrate recogni-
tion domain; SP, serine protease; SS, inter-chain disulphide
bonds.
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of the collagenous stem of MBL.
Other studies have shown that the
calcium binding sites of both CUB
domains of MASP are involved in
MBL binding (Teillet et al., 2008).
To visualize the MBL-MASP
contact region, Gingras et al.
(2011) co-crystallized the smallest
interacting units, a single CUB
domain (CUB2 of MASP-1), and a
synthetic collagen peptide contain-
ing the critical Gly-Lys-Leu triplet
of the MBL stem. The resulting
crystal structure agrees nicely with
the predictions from mutagen-
esis—the MBL lysine, Lys46, binds
to the calcium ligands of the CUB2
domain, and two other CUB2 resi-
dues previously implicated in MBL
binding, His218 and Tyr225, make
seemingly crucial hydrogen bonds
with the collagen main chain (Fig-
ure 2). What is surprising, however,
is how little of the collagen triple
helix is engaged in complex forma-tion. Compared with the collagen com-
plexes of the integrin a2 I domain (Emsley
et al., 2000) and discoidin domainFigure 2. Details of Collagen Recognition in the CUB2-
Collagen Complex
The side chains of theMBL bindingmotif, OGKLGP (O, hydroxy-
proline) are shown in each collagen chain. In the alignment at the
top, K46 (leading) and O44 (trailing) are boxed to indicate their
spatial proximity. The alternative, unfavorable, pairings of K46
with L47 are boxedwith broken lines. The leading chain is shown
twice to emphasize the circular nature of the relationship
between the chains.receptor 2 (Carafoli et al., 2009),
the collagen surface area buried in
the MBL-CUB2 complex is only
about half as large, totalling
a meager 330 A˚2. This small inter-
face does not allow for very tight
binding, but in the multivalent
MBL-MASP complex, the modest
dissociation constant of a single
MBL-CUB contact is amplified by
several orders of magnitude (Chen
and Wallis, 2001; Teillet et al.,
2005). As might be expected from
the dominant contribution of MBL
Lys46 to MASP binding, primary
amines interfere with the MBL-
MASP interaction and, at very high
concentrations, inhibit complement
activation (Gingras et al., 2011).
Whether it is possible to enhance
the potency of amine-based inhibi-
tors remains to be seen, but the
small size and hydrophilic nature of
the MBL-MASP contact might not
bode well for this enterprise.
A unique complication of protein
interactions with the collagen triple
helix is that the three collagen
chains are not equivalent because
of the one-residue stagger betweenchains (Brodsky and Persikov, 2005). The
three chains are referred to as the leading,
middle, and trailing chains (Emsley et al.,Structure 19, November 9, 2011 ª20112000), and proteins always interact
with at least two chains when
binding to collagen. The MBL-
CUB2 structure is the first example
of an interaction with the leading-
trailing chain pair (Figure 2). Why is
Lys46 of the leading chain selected
for CUB2 binding? In the crystal
structure, the side chains of CUB2
residues His218 and Tyr225 point
into a groove in the collagen triple
helix and make hydrogen bonds
with two carbonyl oxygens. This
groove is accessible because the
residue adjacent to Lys46 is an
imino acid, hydroxyproline 44. If
the middle or trailing chains pro-
vided Lys46 for binding, the groove
would be blocked by the leucine
side chain of the adjacent Gly-Lys-
Leu triplet. A similar argument is
made by Gingras et al. (2011) to
explain the orientation of the
collagen peptide.
What does the new structure tell
us about the mechanism of MASPactivation? Here, I must admit to being
less sanguine than Gingras et al. (2011)
are in their discussion. They show that ex-tending the collagen peptide at the
N-terminus would lead to the cross-
over of two MBL stems bound to
a MASP dimer and suggest that the
MBL-MASP complex is, therefore,
in a strained state. Binding to a path-
ogen surface is proposed to release
this strain and trigger MASP activa-
tion. However, the same group has
recently shown that complement
activity is remarkably tolerant to
changes in size and orientation
of theMBL stems (VenkatramanGir-
ija et al., 2010), which, to my mind,
weakens the case for a strained-to-
relaxed mechanism. An alternative
scenario, originally proposed for
the C1 complex that initiates the
classical pathway of complement
activation (Budayova-Spano et al.,
2002), is that the serine protease is
activated by mechanical stress re-
sulting from target binding. Finally,
it is not known which of the MASP
CUB domains are preferentially
bound to the MBL stems. Mutation
of either CUB1 or CUB2 reduces,
but does not abolish, MBL binding,
so either all four CUB domains in
a dimer bind a stem or there areElsevier Ltd All rights reserved 1539
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Previewstwo alternative arrangements with two
stems per dimer (Chen and Wallis, 2001;
Teillet et al., 2008). Clearly, further bio-
chemical studies are required to under-
stand the activation mechanism, but at
least we are no longer in the dark about
a critical connection in the MBL-MASP
assembly.
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Structural and biochemical data reported by Tirado-Lee et al. (2011) in this issue of Structure reveal the
existence of high and low affinity ABC transporters for the same substrate in a single organism, thus raising
questions about structural and mechanistic differences within the ABC superfamily.ATP binding-cassette (ABC) transporters
couple ATP hydrolysis to vectorial move-
ment of substrates across cell mem-
branes. Of ancient origin and ubiquitous
occurrence, they have been adapted to
traffic a vast array of compounds, per-
forming roles such as nutrient import
and removal of toxins, antigen presenta-
tion, hormone release, signal reception,
channel gating, andmany others (Higgins,
1992; Jones and George, 2004). Their
central roles in many physiological pro-
cess has brought ABC transporters to
the forefront in biomedical research in
diverse areas including multidrug resis-
tance in cancers and human genetic dis-
orders, such as cystic fibrosis.
The conserved core architecture com-
prises two transmembrane domains
(TMDs) that form the translocation con-
duit and contain the substrate binding
site(s), and two nucleotide binding do-
mains (NBDs) that form two ATP-binding
sites that hydrolyse ATP cooperatively.Bacterial importers have an associated
periplasmic substrate binding protein
(PBP) that delivers the substrate to the
TMDs. The general architecture of all
PBPs consists of two globular domains,
with a binding pocket located in the cleft
formed between them. While the NBDs
are highly conserved in sequence and
structure, the sequences of the TMDs
are not, reflecting their role in binding and
forming a channel for diverse substrates.
Crystallographic analyses in recent
years have produced three radically dif-
ferent architectures for the TMDs of ABC
transporters (Jones et al., 2009); one for
multidrug resistance-type exporters, and
two for bacterial importers, the latter
designated types I and II. This result was
unexpected, since phylogenetic analyses
of the PBPs and NBDs are closely corre-
lated, giving no indication of divergence
in their intervening cognate TMDs (Saurin
et al., 1999). In addition, despite the exis-
tence of numerous NBD crystal struc-tures, no systematic differences between
the NBDs of the different classes of im-
porters have been identified. It thus had
been expected that ABC transporters
evolved from a single progenitor (Saurin
et al., 1999), and the reason for the dif-
ferent structures of the TMDs has been a
question of interest (Jones et al., 2009).
A seemingly plausible explanation is that
different kinds of substrate are more ef-
fectively handled by different TMD struc-
tures. Indeed, type I structures include
the maltose (MalFGK2), molybdate (Mb;
ModABC), and methionine (MetNI) sys-
tems and type II includes BtuCDF (vitamin
B12) and HI1470/71, and the structural
classification correlates with the phyloge-
netic classification for these systems,
with the two sets of transporters grouped
on two distinct branches. In addition,
because the previously unknown sub-
strate of HI1470/71 was presumed to be
a metal chelate, the structural differences
between the type I and II importers also
